Want to join the conversation?
For 2016, $KMI expects EBITDA to be about 3% below its plan and distributable cash flow to be about 4% below its plan. $KMI expects to achieve its targeted year-end debt to EBITDA ratio of 5.5 times. $KMI's growth capital forecast for 2016 is approx. $2.9Bil, a reduction of $400MM from its budget of approx. $3.3Bil.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.